Calls
1
u/VoidAndOcean
Reddit r/wallstreetbets
Win Rate
0.0%
return
-1.9%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 21
$154.72
-1.9%
Author argues MRNA’s market cap is still low relative to existing cancer-therapy revenue benchmarks and future cancer-market opportunity; short interest remains high. High short interest + valuation repricing potential creates a squeeze-friendly setup that could push MRNA toward the author’s $250–$300 target. Long MRNA as a momentum/valuation squeeze play, but the higher-conviction part of the thesis depends on speculative long-term drug revenue. Short squeezes can reverse sharply; clinical/regulatory setbacks; Merck profit-sharing limits per-drug economics; “intersimeran” revenue is speculative; author already banked $2.4M in profits.
Author argues MRNA’s market cap is still low relative to existing cancer-therapy revenue benchmarks and future cancer-market opportunity; short interest remains high. High short interest + valuation repricing potential creates a squeeze-friendly setup that could push MRNA toward the author’s $250–$300 target. Long MRNA as a momentum/valuation squeeze play, but the higher-conviction part of the thesis depends on speculative long-term drug revenue. Short squeezes can reverse sharply; clinical/regulatory setbacks; Merck profit-sharing limits per-drug economics; “intersimeran” revenue is speculative; author already banked $2.4M in profits.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/VoidAndOcean has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: MRNA.
